LONDON--(BUSINESS WIRE)--
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. | |
| Company dealt in | WILLIS TOWERS WATSON PLC | |
| Class of relevant security to which the | ORD | |
| dealings being disclosed relate (Note 2) | ||
| Date of dealing | 07 April 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD | ||||
| Long | Short | ||||
| Number | (%) | Number | (%) | ||
(1) |
Relevant securities | ||||
1,731,248 |
1.34% |
190,461 |
0.15% |
||
|
|
|
|
||
(2) |
Derivatives (other than options): |
|
|
|
|
102,359 |
0.08% |
7,100 |
0.01% |
||
|
|
|
|
||
(3) |
Options and agreements to |
|
|
|
|
| purchase/sell: | 6,100 |
0.00% |
6,100 |
0.00% |
|
|
|
|
|
||
| TOTAL: |
|
|
|
|
|
1,839,707 |
1.43% |
203,661 |
0.16% |
||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: |
Long |
Short |
||||
|
Number |
|
(%) |
Number |
|
(%) |
(1) Relevant securities |
|
|
||||
(2) Derivatives (other than options) |
|
|
||||
(3) Options and agreements to purchase/sell |
|
|
||||
Total |
|
|
||||
|
||||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
| Purchase/sale | Number of relevant securities | Price per unit |
Purchase |
2 |
237.5800 USD |
Purchase |
8 |
237.3200 USD |
Purchase |
8 |
237.3500 USD |
Purchase |
16 |
237.3300 USD |
Purchase |
16 |
237.3600 USD |
Purchase |
35 |
238.6380 USD |
Purchase |
40 |
238.4900 USD |
Purchase |
45 |
238.5966 USD |
Purchase |
51 |
237.8600 USD |
Purchase |
79 |
238.7462 USD |
Purchase |
96 |
237.8740 USD |
Purchase |
323 |
238.6077 USD |
Purchase |
395 |
238.6516 USD |
Purchase |
562 |
237.4608 USD |
Purchase |
1,422 |
237.7981 USD |
Purchase |
1,570 |
237.9417 USD |
Purchase |
1,855 |
237.8310 USD |
Purchase |
1,920 |
237.8300 USD |
Purchase |
2,602 |
237.8672 USD |
Purchase |
2,853 |
238.5976 USD |
Purchase |
4,022 |
238.5852 USD |
Purchase |
4,040 |
238.6155 USD |
Purchase |
5,023 |
238.0492 USD |
Purchase |
5,477 |
237.5992 USD |
Purchase |
7,793 |
237.9105 USD |
Sale |
1 |
238.6800 USD |
Sale |
1 |
237.7750 USD |
Sale |
2 |
238.4800 USD |
Sale |
65 |
238.0600 USD |
Sale |
100 |
236.8100 USD |
Sale |
100 |
237.7100 USD |
Sale |
100 |
238.1672 USD |
Sale |
110 |
238.4900 USD |
Sale |
132 |
238.1171 USD |
Sale |
144 |
237.8740 USD |
Sale |
193 |
238.1110 USD |
Sale |
193 |
238.1296 USD |
Sale |
200 |
238.0450 USD |
Sale |
271 |
237.9700 USD |
Sale |
385 |
238.1386 USD |
Sale |
400 |
238.0350 USD |
Sale |
444 |
238.0399 USD |
Sale |
450 |
238.0711 USD |
Sale |
562 |
237.4608 USD |
Sale |
632 |
238.1617 USD |
Sale |
650 |
238.0523 USD |
Sale |
667 |
237.8292 USD |
Sale |
697 |
238.0408 USD |
Sale |
725 |
238.0100 USD |
Sale |
836 |
237.8300 USD |
Sale |
1,185 |
238.1573 USD |
Sale |
1,260 |
238.0677 USD |
Sale |
1,421 |
237.7981 USD |
Sale |
1,432 |
237.4302 USD |
Sale |
1,623 |
238.4870 USD |
Sale |
1,779 |
238.1069 USD |
Sale |
1,863 |
237.4133 USD |
Sale |
1,924 |
237.7560 USD |
Sale |
2,272 |
237.8303 USD |
Sale |
3,338 |
238.0647 USD |
Sale |
4,096 |
237.6616 USD |
Sale |
10,000 |
238.6055 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD |
Nature of transaction (Note 6) |
Number of relevant securities (Note 7) |
Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option |
Writing, selling, purchasing, varying etc. |
Number of securities to which the option relates (Note 7) |
Exercise price |
Type, e.g. American, European etc. |
Expiry date |
Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option |
Number of securities |
Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) |
Details |
Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
| Is a Supplemental Form 8 (Open Positions) attached? | YES |
| Date of disclosure: | 8 Apr 2021 |
| Contact name: | Large Holdings Regulatory Operations |
| Telephone number: | 020 3134 7213 |
| If a connected EFM, name of offeree/offeror with which connected | |
| If a connected EFM, state nature of connection |
Ap23
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
| Product name | Written or | Number of | Exercise | Type | Expiry |
| purchased | relevant securities | price | date | ||
| to which the option | |||||
| or derivative | |||||
| relates | |||||
Put Options |
Purchased |
-100 |
220.0000 |
American |
Jul 16, 2021 |
Call Options |
Purchased |
100 |
240.0000 |
American |
Jul 16, 2021 |
Call Options |
Purchased |
6,000 |
220.0000 |
American |
Jul 16, 2021 |
Put Options |
Purchased |
-6,000 |
200.0000 |
American |
Jul 16, 2021 |
Notes
1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.